Cyltezo
FDA Approves Cyltezo Autoinjector
The FDA approved an autoinjector option for Cyltezo, an interchangeable biosimilar of Humira.
MAY 23, 2023
FDA Approves Cyltezo, Biosimilar of Humira
Second new adalimumab biosimilar approved for multiple indications.
AUGUST 28, 2017
Load more